Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contezolid vs linezolid for complicated skin and soft tissue infection
CTR20231611Phase 3Completed
- Sponsor
- Morningside Pharmaceuticals
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of contezolid in skin and soft tissue infections (SSTIs), sponsored by Morningside Pharmaceuticals. Started May 2023; status: completed.
02
Drugs
contezolid
03
Conditions
skin and soft tissue infections (SSTIs)
Beyond the preview
Go deeper on CTR20231611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231611.